Open, parallel, prospective, randomized study between tamsulosin and tadalafil for male LUTS patients.
Not Applicable
Completed
- Conditions
- Benign prostatic hyperplasia
- Registration Number
- JPRN-UMIN000020362
- Lead Sponsor
- Japan Labour Health and Welfare Organization, Kanto Rosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with ongoing administration of anti-cholinergic drugs, beta-3 receptor stimulants, anti-depressants, anxiolytic, and flavoxate hydrochloride. Patients ever administered with 5 alfa-reductase inhibitors and chlormadinone acetate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method